ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 72 filers reported holding ANTARES PHARMA INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $53,000 | +26.2% | 16,613 | +12.2% | 0.02% | +50.0% |
| Q1 2017 | $42,000 | -32.3% | 14,800 | -44.2% | 0.01% | -17.6% |
| Q4 2016 | $62,000 | -60.3% | 26,516 | -71.4% | 0.02% | -54.1% |
| Q3 2016 | $156,000 | +642.9% | 92,599 | +424.9% | 0.04% | +1750.0% |
| Q4 2015 | $21,000 | -91.1% | 17,642 | -87.4% | 0.00% | -91.3% |
| Q3 2015 | $237,000 | -0.4% | 139,642 | +22.0% | 0.02% | 0.0% |
| Q2 2015 | $238,000 | -12.5% | 114,430 | +13.9% | 0.02% | -14.8% |
| Q1 2015 | $272,000 | -14.2% | 100,453 | -18.6% | 0.03% | -10.0% |
| Q4 2014 | $317,000 | +6.0% | 123,418 | -24.5% | 0.03% | +15.4% |
| Q3 2014 | $299,000 | +149.2% | 163,407 | +264.0% | 0.03% | +188.9% |
| Q2 2014 | $120,000 | – | 44,886 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sargent Investment Group, LLC | 3,096,355 | $8,422,000 | 5.18% |
| JW Asset Management, LLC | 1,920,524 | $5,224,000 | 3.85% |
| Healthcare Value Capital, LLC | 250,000 | $680,000 | 2.64% |
| ARMISTICE CAPITAL, LLC | 10,300,000 | $28,016,000 | 2.12% |
| Broadfin Capital, LLC | 3,444,147 | $9,368,000 | 1.23% |
| PERKINS CAPITAL MANAGEMENT INC | 409,000 | $1,112,000 | 0.86% |
| MYCIO WEALTH PARTNERS, LLC | 1,896,500 | $5,158,000 | 0.48% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 1,012,600 | $2,754,000 | 0.22% |
| FALCON POINT CAPITAL, LLC | 130,200 | $354,000 | 0.21% |
| Brown Advisory Securities, LLC | 275,000 | $781,000 | 0.15% |